For years, the global medical community has grappled with the challenge of superbugs—bacteria that have developed resistance to standard treatments, claiming over 1.2 million lives annually. These organisms evolve quickly, rendering many antibiotics ineffective and leaving us in a perpetual race against microbial resistance. In a significant breakthrough, the European Commission has recently approved Emblaveo, […]
